服务热线
15339069646服务热线
15339069646| Item | Cat. No. | Application | Isotype |
| Anti-C5 mAbs [Vilobelimab Biosimilar] (MABL-5416) | MABL-5416 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-ADCYAP1/PACAP mAbs [Vipalanebart Biosimilar] (MABL-5417) | MABL-5417 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-CD3E mAbs [Visilizumab Biosimilar] (MABL-5418) | MABL-5418 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-SIRPA mAbs [Vislarafusp Biosimilar] (MABL-5419) | MABL-5419 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-GDF15/MIC1/MIC-1/NAG1/NAG-1/PTGFB mAbs [Visugromab Biosimilar] (MABL-5420) | MABL-5420 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-OSMR mAbs [Vixarelimab Biosimilar] (MABL-5421) | MABL-5421 | ELISA, FACS, Functional assay, in vivo binding | G4-G1, Lambda |
| Anti-NPR1/ANPRA/ANPa/GUC2A/GUCY2A/NPRA mAbs [Vixticibart Biosimilar] (MABL-5422) | MABL-5422 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-CD3E;SIGLEC3/CD33/p67 mAbs [Vixtimotamab Biosimilar] (MABL-5423) | MABL-5423 | ELISA, FACS, Functional assay, in vivo binding | na;na, Kappa;Lambda |
| Anti-IL6R/CD126;ALB mAbs [Vobarilizumab Biosimilar] (MABL-5424) | MABL-5424 | ELISA, FACS, Functional assay, in vivo binding | na;na, na;na |
| Anti-B7H3/CD276 mAbs [Vobramitamab Biosimilar] (MABL-5425) | MABL-5425 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-FGFR3/CD333 mAbs [Vofatamab Biosimilar] (MABL-5426) | MABL-5426 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-GCCR/NR3C1 mAbs [Volagidemab Biosimilar] (MABL-5427) | MABL-5427 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-ITGA5B1 mAbs [Volociximab Biosimilar] (MABL-5428) | MABL-5428 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-CTLA4/CD152;PDCD1/CD279/PD1 mAbs [Volrustomig Biosimilar] (MABL-5429) | MABL-5429 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa;Kappa |
| Anti-IGF1R/CD221 mAbs [Veligrotug Biosimilar] (MABL-5402) | MABL-5402 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TNFRSF17/CD269/BCMA/TNFRSF13A;CD3E mAbs [Velinotamig Biosimilar] (MABL-5403) | MABL-5403 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, Kappa;Kappa |
| Anti-MS4A1/CD20 mAbs [Veltuzumab Biosimilar] (MABL-5404) | MABL-5404 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-BTLA/CD272 mAbs [Venanprubart Biosimilar] (MABL-5405) | MABL-5405 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-C5 mAbs [Vensobafusp Biosimilar] (MABL-5406) | MABL-5406 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-MUC17;CD3E mAbs [Vepsitamab Biosimilar] (MABL-5407) | MABL-5407 | ELISA, FACS, Functional assay, in vivo binding | na;na, Lambda;Lambda |
联系我们
Copyright © 2012-2029 西安迈博睿（Mabioway）生物科技有限公司 版权所有
地址：陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话：15339069646 邮箱：info@mabioway.cn